I Sadek1, P Biron, T Kus. 1. Department of Pharmacology, Université de Montréal, Research Centre, Hôpital du Sacré coeur, Québec.
Abstract
OBJECTIVE: To report a new case and review the literature of amiodarone-related epididymitis to improve knowledge of the clinical characteristics of this reaction. DESIGN: Cohort study. SETTING: Tertiary out-patient arrhythmia clinic. PATIENTS: Males currently treated for arrhythmias with amiodarone for at least two months. Thirty-two patients were identified and all were contacted. OUTCOME MEASURES: Swelling and or/pain in the scrotum with confirmation of noninfectious epididymitis by a urologist. DATA SOURCES: Bibliography (Medline and Embase) and databases (Manufacturer, Health Protection Branch, World Health Organisation). STUDY SELECTION: Four articles with case reports. Databases searched for these key words: amiodarone and epididymitis. RESULTS: A new case is reported. Twelve cases have been presented individually and six more described collectively. Times to onset range from four to 71 months, daily doses range from 200 to 800 mg. The reaction is self-limited, with or without amiodarone reduction, and does not require antimicrobial drugs, but a noninvasive urological examination may be warranted. CONCLUSION: Awareness by cardiologists will prevent unnecessary invasive urological investigations or antibiotic therapy.
OBJECTIVE: To report a new case and review the literature of amiodarone-related epididymitis to improve knowledge of the clinical characteristics of this reaction. DESIGN: Cohort study. SETTING: Tertiary out-patientarrhythmia clinic. PATIENTS: Males currently treated for arrhythmias with amiodarone for at least two months. Thirty-two patients were identified and all were contacted. OUTCOME MEASURES: Swelling and or/pain in the scrotum with confirmation of noninfectious epididymitis by a urologist. DATA SOURCES: Bibliography (Medline and Embase) and databases (Manufacturer, Health Protection Branch, World Health Organisation). STUDY SELECTION: Four articles with case reports. Databases searched for these key words: amiodarone and epididymitis. RESULTS: A new case is reported. Twelve cases have been presented individually and six more described collectively. Times to onset range from four to 71 months, daily doses range from 200 to 800 mg. The reaction is self-limited, with or without amiodarone reduction, and does not require antimicrobial drugs, but a noninvasive urological examination may be warranted. CONCLUSION: Awareness by cardiologists will prevent unnecessary invasive urological investigations or antibiotic therapy.